Premium
EFFECTS ON THE HUMAN IMMUNE SYSTEM AFTER OBINUTUZUMAB MONOTHERAPY TREATMENT
Author(s) -
GarciaMunoz R.,
Aguinaga L.,
Feliu J.,
AntonRemirez J.,
Jorge del Val L.,
DominguezGarrido E.,
Rabasa P.,
Panizo C.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2439_147
Subject(s) - obinutuzumab , cd20 , antibody dependent cell mediated cytotoxicity , chronic lymphocytic leukemia , medicine , immune system , immunology , cd19 , cd8 , monoclonal antibody , lymphocyte , antibody , cancer research , leukemia
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom